EIF2A and glioblastoma: Therefore, to explore the role played by a sustained increase of P-eIF2α in PED-GBM survival and response to treatments, we employed inhibitors of P-eIF2α dephosphorylation and the S51D phosphomimetic variant of eIF2α.